ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE

Show other versions (1)

Questions of metabolite therapy with drugs based on glutamic acid in patients with chronic heart failure are considered. Possible modes of action of these drugs are presented. Results of the proper study of glutamic acid based drug in chronic heart failure are presented as examples.

Bibliographic Details
Main Authors:	L. N. Maksimova, M. L. Maksimov, Y. R. Nartsissov, R. M. Zaslavskaya, E. V. Kalinina
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	хроническая сердечная недостаточность метаболитная терапия глутатион
Online Access:	http://www.rpcardio.ru/jour/article/view/241

Similar Items

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. M. Zaslavskaya, et al.
Published: (2015-12-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

ПРОБЛЕМА ОТСУТСТВИЯ ОТВЕТА НА КАРДИОРЕСИНХРОНИЗАЦИОННУЮ ТЕРАПИЮ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: S. I. Stupakov
Published: (2015-10-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Tissue Doppler study in the diagnosis of functional disorders of the myocardium in patients with chronic heart failure
by: A S Skosyrev, et al.
Published: (2010-06-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

«Grey zone» of heart failure
by: P Yu Galin, et al.
Published: (2018-08-01)

PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE
by: O. A. Shtegman
Published: (2015-09-01)

HYPERURICEMIA AS A PREDICTOR OF CHRONIC HEART FAILURE
by: M. V. Ledyakhova, et al.
Published: (2015-09-01)

Influence of diuretic therapy on the features of heart rhythm variability changes in chronic heart failure patients
by: K R Alyeva, et al.
Published: (2018-02-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

Positive effect of if-channel’s blocker ivabradine therapy in a patient with ischemic chronic heart failure with preserved left ventricle ejection fraction and hereditary thrombophilia (clinical case)
by: Iurii N. Belenkov, et al.
Published: (2019-09-01)

CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN: ROLE OF CHRONIC PULMONARY OBSTRUCTIVE DISEASE
by: N. T. Vatutin, et al.
Published: (2016-08-01)

Clinical efficacy of AT1-receptors of angiotensin II valsartan in the pharmacotherapy of patients with arterial hypertension and chronic heart failure
by: A K Starodubtsev, et al.
Published: (2010-12-01)

Hybrid approach to treatment of patients with severe heart failure and arrhythmia
by: O. V. Sapelnikov, et al.
Published: (2017-07-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

Beta-adrenoblocker therapy in patients with severe chronic heart failure
by: I. I. Sinitsyna, et al.
Published: (2007-02-01)

CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET"
by: S. F. Berkinbaev, et al.
Published: (2015-09-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

Фармакоэкономический анализ применения левосимендана у больных с тяжёлой декомпенсированной хронической сердечной недостаточностью
Published: (2018-06-01)

Endokrinnye mekhanizmy modulyatsii serdechnoydeyatel'nosti u patsientov s khronicheskoyserdechnoy nedostatochnost'yu: rol' gormona rosta
Published: (2010-12-01)

ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS
by: Lei Zhang, et al.
Published: (2015-12-01)

RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE
by: T. G. Kulikova, et al.
Published: (2015-09-01)

Pathophysiologic aspects of the development of cognitive disorders in chronic heart failure in elderly patients
by: M A Pokachalova, et al.
Published: (2018-04-01)

Multi-polar stimulation of the left ventricle during cardio-resynchronisation therapy in patients with congestive heart failure: Randomised pilot study outcomes from parallel groups
by: A. V. Ponomarenko, et al.
Published: (2020-04-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

Взаимосвязь механических паттернов блокады левой ножки пучка Гиса и суперответа при сердечной ресинхронизирующей терапии у пациентов с хронической сердечной недостаточностью
Published: (2020-02-01)

EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2015-09-01)

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

FEATURES OF PIRIBEDIL USE IN THE TREATMENT OF MILD COGNITIVE IMPAIRMENTS IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. S. Akimova, et al.
Published: (2015-09-01)

Influence of prolonged cryopreservation on the number and functional activity of stem/progenitor cells derived after G-CSF mobilization from patients with chronic heart failure
by: Н. А. Бондаренко, et al.
Published: (2015-10-01)

Russian National Research Medical University named after N.I. Pirogov, Moscow
by: V. N. Larina, et al.
Published: (2015-09-01)